Healtheast Medical Research Institute
Healtheast Medical Research Institute was paid $4.07M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
WOODBURY, MN 55125
Next to other Durable Medical Equipment & Medical Supplies providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,834 | $212K | |
| 2019 | 21,358 | $704K | |
| 2020 | 16,800 | $640K | |
| 2021 | 24,287 | $881K | |
| 2022 | 15,809 | $607K | |
| 2023 | 11,623 | $585K | |
| 2024incomplete | 9,663 | $439K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 21,249 | 19,529 | $1.04M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 13,335 | 12,089 | $845K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 9.2% | 9,395 | 9,074 | $372K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 5.3% | 395 | 238 | $217K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.2% | 2,578 | 2,478 | $213K |
| X5622 | 4.2% | 3,561 | 3,434 | $172K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.2% | 2,423 | 2,378 | $170K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.8% | 2,870 | 2,713 | $156K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.2% | 2,043 | 1,970 | $129K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.7% | 4,052 | 3,917 | $111K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 4,298 | 4,176 | $57K |
| 90461 | 1.1% | 2,136 | 2,076 | $46K |
89 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,608 | $38K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 385 | $38K |
| 99188 | <1% | 4,392 | $37K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,908 | $32K |
| 0002A | <1% | 1,281 | $32K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 980 | $31K |
| 0001A | <1% | 1,385 | $30K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,849 | $25K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,459 | $25K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 303 | $23K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 435 | $16K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 144 | $16K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 277 | $15K |
| 92551 | <1% | 2,226 | $14K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,950 | $14K |
| 90686 | <1% | 2,956 | $11K | |
| 0004A | <1% | 239 | $9K | |
| 87650 | <1% | 569 | $8K | |
| 0054A | <1% | 242 | $8K | |
| 0072A | <1% | 192 | $8K | |
| 0071A | <1% | 224 | $8K | |
| 91320 | <1% | 85 | $8K | |
| 96127 | <1% | 1,935 | $7K | |
| 95874 | <1% | 187 | $7K | |
| 99243 | <1% | 74 | $5K | |
| 90480 | <1% | 166 | $5K | |
| 80061 | Lipid panel | <1% | 375 | $5K |
| 90670 | <1% | 1,450 | $5K | |
| 80053 | Comprehensive metabolic panel | <1% | 455 | $4K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 18 | $4K |
| 95117 | <1% | 529 | $4K | |
| 0064A | <1% | 80 | $3K | |
| 0082A | <1% | 96 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 109 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 188 | $3K |
| 99173 | <1% | 2,248 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 285 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 343 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 147 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 58 | $2K |
| 85027 | <1% | 354 | $2K | |
| 85018 | <1% | 1,005 | $2K | |
| 0124A | <1% | 59 | $2K | |
| 99000 | <1% | 114 | $2K | |
| 99442 | <1% | 45 | $1K | |
| 77080 | <1% | 66 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $1K |
| 0083A | <1% | 31 | $1K | |
| 0081A | <1% | 38 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 138 | $1K |
| 90688 | <1% | 488 | $1K | |
| 92557 | <1% | 45 | $948.00 | |
| 64615 | <1% | 13 | $920.13 | |
| 96161 | <1% | 477 | $814.20 | |
| 99421 | <1% | 85 | $791.77 | |
| 0074A | <1% | 15 | $621.98 | |
| 90656 | <1% | 310 | $504.26 | |
| 36416 | <1% | 145 | $473.09 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $459.78 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $459.78 |
| 83655 | <1% | 29 | $352.00 | |
| 73562 | <1% | 16 | $349.32 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 50 | $303.55 |
| 99441 | <1% | 15 | $294.12 | |
| 92567 | <1% | 28 | $284.28 | |
| 81001 | <1% | 84 | $259.12 | |
| 90473 | <1% | 12 | $254.64 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $244.12 |
| 87186 | <1% | 40 | $226.82 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 25 | $204.52 |
| G0008 | Administration of influenza virus vaccine | <1% | 20 | $195.11 |
| 90680 | <1% | 329 | $186.80 | |
| 90723 | <1% | 606 | $176.62 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 61 | $176.61 |
| 87807 | <1% | 13 | $159.80 | |
| 87210 | <1% | 25 | $145.89 | |
| 92550 | <1% | 12 | $116.24 | |
| 82043 | <1% | 13 | $76.26 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 109 | $64.62 |
| 85652 | <1% | 15 | $41.63 | |
| 90648 | <1% | 1,227 | $31.43 | |
| 81003 | <1% | 13 | $26.90 | |
| 90697 | 0% | 30 | $0.00 | |
| 90677 | 0% | 61 | $0.00 | |
| 91319 | 0% | 12 | $0.00 | |
| 90633 | 0% | 109 | $0.00 | |
| 91300 | 0% | 515 | $0.00 | |
| 90685 | 0% | 244 | $0.00 | |
| 90715 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Fairview Clinics | Princeton, MN | $4.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.